Understanding IBD Complications: Strictures, Deficiencies, and Long-Term Risks

Inflammatory bowel disease (IBD) is a chronic condition marked by cycles of remission and flare, and while managing day-to-day symptoms is a priority, understanding potential IBD complications is essential for protecting long-term health. Complications can develop inside the digestive tract — including strictures, fistulas, and abscesses — or well beyond it, affecting joints, skin, eyes, and bones. This article explains the most common intestinal and extraintestinal complications, why symptoms alone do not always reveal what is happening in the gut, how IBD is linked with gut microbiome imbalance, and how a gut microbiome test may add useful context alongside standard medical care.

Understanding IBD Complications

Inflammatory bowel disease is an umbrella term for chronic, immune-mediated inflammation of the gastrointestinal tract. The two main forms are Crohn's disease, which can affect any part of the digestive tract and often involves deeper layers of the bowel wall, and ulcerative colitis, which is limited to the colon and rectum. Both follow a relapsing course, alternating between active flares and periods of remission.

View example recommendations from the InnerBuddies platform Preview the nutrition, supplement, food diary and food recipe platform recommendations that InnerBuddies can generate based on your gut microbiome test

Complications differ from everyday symptoms. They are the structural, functional, or whole-body changes that can accumulate over time, often as a result of prolonged or poorly controlled inflammation. They fall broadly into two groups: intestinal complications, located in or around the bowel, and extraintestinal complications, which involve other organ systems. Understanding both is central to proactive, long-term management.

Intestinal Complications of IBD: What Happens in the Gut

Intestinal complications are not simply symptoms of a flare. They are structural or functional changes that develop when inflammation persists or repeatedly returns. The three major mechanical complications are strictures, fistulas, and abscesses.

Strictures are narrowed sections of bowel caused by swelling and scar tissue. As the passageway tightens, food may struggle to move through, causing cramping, bloating, abdominal pain, and sometimes obstruction. Management depends on whether the narrowing is mainly inflammatory or fibrotic, and may involve medication, endoscopic procedures, or surgery.
Fistulas are abnormal tunnels connecting the bowel to another organ, such as the bladder, or to the skin. They are more common in Crohn's disease, where inflammation penetrates the full thickness of the bowel wall. Symptoms vary by location and can include drainage, pain, and recurrent infections; treatment often combines medication with surgical repair.
Abscesses are pockets of pus that can form near an inflamed segment of intestine, typically causing fever, localized pain, and feeling generally unwell. They usually require drainage together with antibiotics, which is why new or worsening pain, fever, or swelling always warrants prompt medical assessment.

The Risk of Colon Cancer in IBD

Long-standing inflammation in the colon is associated with a higher relative risk of colorectal cancer compared with the general population, and research indicates this risk rises with the duration and extent of colonic disease, particularly in ulcerative colitis. This is educational context rather than a cause for alarm: the risk develops gradually over many years, which is exactly why monitoring works. Regular surveillance colonoscopies are the standard of care for significant colonic involvement because they allow physicians to detect and remove precancerous changes early.

Microscopic Inflammation vs. Structural Damage

It also helps to separate microscopic inflammation from structural damage. Microscopic inflammation is immune activity visible only when tissue samples are examined; structural damage — scars and strictures — is the fixed end result of prolonged disease. The two do not move in lockstep: a person can feel relatively well while low-grade inflammation quietly contributes to structural problems. This gap between how someone feels and what is happening at the tissue level is a central challenge in IBD care, and it is why clinicians increasingly aim for measurable healing of the bowel lining, not just symptom relief.

Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

Extraintestinal Complications: How IBD Affects the Whole Body

IBD is not a gut-only disease. The immune inflammation driving it is systemic, and it can manifest outside the digestive tract — sometimes before significant gut symptoms appear, or during periods when bowel disease seems quiet.

Joint Pain, Skin Issues, and Eye Inflammation

Joint pain and arthritis are the most common extraintestinal manifestations. Skin involvement includes erythema nodosum, tender red nodules usually on the shins, and the rarer pyoderma gangrenosum, which causes painful ulcers. Eye inflammation, such as uveitis, is less common but needs prompt specialist attention because it can threaten vision. These are systemic inflammatory responses, and they are often treated by controlling the underlying gut inflammation, sometimes with input from rheumatology, dermatology, or ophthalmology.

Long-Term Risks and Associated Conditions

IBD is also associated with an increased risk of blood clots, particularly during flares and hospitalizations. Bone health can suffer through chronic inflammation, reduced absorption of calcium and vitamin D, and corticosteroid use, making osteoporosis a recognized concern. Nutrient deficiencies are more common as well: chronic intestinal blood loss can lead to iron deficiency and anemia, while Crohn's disease affecting the ileum can impair vitamin B12 absorption. Managing IBD is therefore a holistic process that extends well beyond the bowel.

The Link Between IBD and Gut Microbiome Imbalance

The gut microbiome — the trillions of bacteria and other microbes in the digestive tract — participates in digestion, immune signaling, and maintenance of the gut lining. Research consistently shows that many people with IBD have a state of dysbiosis, an imbalance in this ecosystem, often marked by reduced microbial diversity, fewer bacteria associated with anti-inflammatory activity, and an expansion of potentially pro-inflammatory species. These observations do not make the microbiome a sole cause of disease, but they suggest it may be an active participant in how inflammation develops and persists.

Does Dysbiosis Cause IBD or Does IBD Cause Dysbiosis?

The honest answer is that the relationship appears to run in both directions. A specific microbiome profile does not, by itself, cause IBD; the disease arises from a combination of genetics, immune dysregulation, environmental factors, and the gut environment. Still, research suggests that a compromised gut barrier combined with dysbiosis may contribute to an inappropriate immune response in genetically predisposed individuals. Meanwhile, inflammation alters conditions inside the gut — affecting mucus and nutrient availability — which can favor inflammation-tolerant bacteria and deepen the imbalance. The result is a plausible feedback loop rather than a one-way cause.

Why Symptoms Alone Don't Tell the Full Story

One of the most important lessons in modern IBD care is the disconnect between how a person feels and what is happening at the tissue level. Symptoms are real and worth tracking, but they are an imperfect signal of underlying inflammation.

Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

Silent Inflammation and the Limits of Symptom Tracking

Inflammation can persist even when a person feels essentially normal — a situation sometimes called silent inflammation. Research has found that symptoms and endoscopic findings do not always align, which is why clinicians also use stool markers such as calprotectin, blood tests, and colonoscopy. Symptom-only monitoring can therefore miss ongoing processes that drive long-term complications. Fatigue illustrates the complexity: it is among the most common IBD symptoms and may be linked with systemic inflammation and microbiome activity, but its absence does not guarantee a quiet gut.

How Gut Microbiome Testing Can Provide Additional Insight

Because symptoms and routine investigations capture different parts of the picture, some people want more information about the gut environment itself. A gut microbiome test is an at-home tool that sequences the DNA of the microbes in a stool sample, creating a snapshot of your unique ecosystem — which microbes are present, in what relative amounts, and which functions they may support. For people with IBD, it offers a way to measure rather than guess when it comes to microbial diversity and composition.

What a Microbiome Test Can Reveal for an IBD Patient

Modern analysis can map overall microbial diversity, the balance between beneficial and opportunistic bacteria, and the abundance of microbes that have been associated with inflammation in research. Some tests also estimate functional potential, such as the capacity to produce short-chain fatty acids, compounds involved in maintaining the gut lining. Read alongside standard clinical care, this data describes the ecosystem in which inflammation occurs — not the inflammation itself — and may help inform diet and lifestyle discussions with a healthcare provider or dietitian.

What a Microbiome Test Cannot Do for an IBD Patient

The limitations matter just as much. A microbiome test cannot diagnose IBD, distinguish Crohn's disease from ulcerative colitis, or predict when a flare will occur. It cannot detect structural damage such as strictures or show what the bowel lining looks like; endoscopy, imaging, and clinical biomarkers remain the tools for that. Nor can it indicate how your immune system will respond to medication. In short, it provides a microbial and functional snapshot, not a clinical verdict.

Should You Consider Microbiome Testing? Factors to Weigh

Gut microbiomes are highly individual: two people with the same IBD diagnosis can have completely different microbial profiles. That individual variability is one reason one-size-fits-all dietary assumptions may be incomplete, and why personal data can be worth having — as long as expectations are realistic.

Situations Where Testing May Be Useful

Testing may add context if you are establishing a baseline before starting a low-FODMAP or elimination diet, if you are in remission but still experiencing persistent fatigue or bloating, or if you want to understand the diversity of your gut ecosystem and follow it over time. Because the microbiome can shift with diet, environment, and life stage, some people use a gut health testing membership to track these changes longitudinally. Such information may support dietary adjustments aimed at fostering a gut environment associated with lower inflammation.

Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

When Testing Is Not a Priority

Testing should never come at the expense of medical care. During an acute flare, treatment is the priority, not a stool test. A microbiome test is also not useful for diagnosing active disease, monitoring how well biologics or immunosuppressants are working, or checking for structural complications — those questions require clinical measures such as calprotectin, endoscopy, and drug monitoring ordered by a gastroenterologist.

Connecting the Dots: Your Microbiome, Your Health Picture

Living well with IBD is a layered journey of medical care, nutrition, and lifestyle. Understanding complications — from strictures and fistulas to joint pain and colorectal cancer risk — explains why proactive, long-term management matters. Within that picture, your microbiome is one meaningful piece of the puzzle. It will not cure IBD or replace your gastroenterologist, but knowing your unique microbial composition adds a personal layer of insight into the ecosystem where inflammation occurs, enabling a more individualized, data-informed approach to diet and wellness.

Key Takeaways

IBD is an umbrella term for chronic gut inflammation, mainly Crohn's disease and ulcerative colitis, which follow cycles of flare and remission.
Intestinal complications such as strictures, fistulas, and abscesses are structural changes that build up over time, distinct from everyday flare symptoms.
Chronic colonic inflammation is associated with a higher relative risk of colorectal cancer, which is why regular surveillance colonoscopies are the standard of care.
IBD can affect the whole body, including joints, skin, eyes, bone health, blood clotting risk, and nutrient status.
Many people with IBD show dysbiosis — reduced microbial diversity and more potentially pro-inflammatory bacteria — although cause and effect are not fully settled.
Feeling well does not always mean the gut is quiet, because microscopic inflammation can persist without noticeable symptoms.
A gut microbiome test can provide a snapshot of microbial diversity and composition, but it cannot diagnose IBD, predict flares, or detect structural damage.
Microbiome results are highly individual and require context, complementing rather than replacing gastroenterology care.

Frequently Asked Questions

What are the most common complications of IBD?

The most frequent intestinal complications are strictures, fistulas, and abscesses, alongside an elevated relative risk of colorectal cancer in long-standing colonic disease. Extraintestinal complications — such as joint pain, skin conditions, eye inflammation, osteoporosis, blood clots, and nutrient deficiencies — are also common and reflect the systemic nature of the inflammation.

Are complications more common in Crohn's disease or ulcerative colitis?

Fistulas and strictures are more characteristic of Crohn's disease, because its inflammation can penetrate the full thickness of the bowel wall. Colorectal cancer risk is most closely studied in ulcerative colitis and in Crohn's disease that involves large portions of the colon. Individual risk depends on disease duration, extent, and activity.

Can complications develop even when symptoms feel well controlled?

Yes. Microscopic inflammation can persist while a person feels relatively well, and over time it may quietly contribute to structural damage such as strictures. This is why clinicians rely on objective markers and endoscopy in addition to symptom reports.

Why does chronic inflammation increase colorectal cancer risk?

Long-standing inflammation exposes the cells lining the colon to an environment that, over many years, can increase the chance of precancerous changes. The risk is linked mainly with disease duration and extent. Because it develops slowly, regular surveillance colonoscopy is an effective way to detect and remove precancerous tissue early.

Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

What is dysbiosis?

Dysbiosis describes an imbalance in the gut microbiome, often characterized by reduced microbial diversity, fewer bacteria associated with anti-inflammatory activity, and a relative increase in potentially pro-inflammatory species. Research has linked dysbiosis with IBD, though the direction of the relationship is not fully settled.

Does an imbalanced microbiome cause IBD?

Not on its own. IBD arises from a combination of genetic susceptibility, immune dysregulation, environmental factors, and the gut environment. Research suggests dysbiosis may contribute to inappropriate immune responses in predisposed individuals, while inflammation itself can also reshape the microbiome, creating a feedback loop.

Can a gut microbiome test diagnose IBD or predict a flare?

No. A microbiome test is not a diagnostic tool and cannot predict when a flare will occur. It describes the composition and potential function of your gut ecosystem, which is useful context but not a clinical verdict.

When might microbiome testing be useful for someone with IBD?

Testing may add context when you are establishing a baseline before dietary changes, when you are in remission but experiencing persistent fatigue or bloating, or when you want to track how your ecosystem changes over time. Results are most useful when interpreted alongside standard clinical care.

When is microbiome testing not a priority?

During an acute flare, medical treatment comes first, and a stool test adds nothing to managing active inflammation. Testing is also not useful for diagnosing active disease, monitoring biologics or immunosuppressants, or checking for structural complications, which require clinical assessment.

Can diet change the gut microbiome?

Diet is one of the strongest influences on microbial composition, and research indicates that changes in eating patterns can shift the microbiome. The nature and persistence of these shifts vary considerably between individuals, so general dietary advice may not translate predictably to any one person.

Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendations

Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data

How often is surveillance colonoscopy needed in IBD?

Surveillance intervals are individualized based on factors such as disease duration, extent of colonic involvement, inflammation severity, and personal risk factors. There is no single schedule that fits everyone, so the appropriate interval should be determined by a gastroenterologist.

Conclusion

The defining feature of IBD is variability — in disease course, in complications, and in the gut microbiome that surrounds the inflammation. Symptoms alone offer an incomplete map of that landscape, which is why clinical monitoring and, for some, additional insight from a personalized microbiome analysis can be valuable. Understanding your unique gut ecosystem will not diagnose or cure IBD, but it may add meaningful context to a management plan built with your care team.